Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
48.1M
-
Shares change
-
-1.74M
-
Total reported value, excl. options
-
$270M
-
Value change
-
-$15.5M
-
Put/Call ratio
-
0.24
-
Number of buys
-
53
-
Number of sells
-
-43
-
Price
-
$5.62
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2019
144 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q3 2019.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.1M shares
of 159M outstanding shares and own 30.29% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (7.52M shares), RA CAPITAL MANAGEMENT, L.P. (6.88M shares), BlackRock Inc. (5.61M shares), VANGUARD GROUP INC (3.92M shares), STATE STREET CORP (3.91M shares), BRIDGER MANAGEMENT, LLC (2.33M shares), FMR LLC (1.84M shares), Sofinnova Investments, Inc. (1.73M shares), GEODE CAPITAL MANAGEMENT, LLC (1.12M shares), and NORTHERN TRUST CORP (1.06M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.